Clinical Trial Update: Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of ralfinamide in chronic neuropathic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Low Back Pain

Drugs mentioned

• Ralfinamide (ralfinamide)

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Pain | Phase 3 | Status: COMPLETED